The Life Science, Health & Wellness TechVision Opportunity Engine (TOE) comprises analytical insights across various innovations. The TOE describes disruptive technological developments across stem cell platforms, personalized medicine, use of artificial intelligence for Alzheimer’s disease, gene therapies, melanoma management, biomarkers, vaccines, liver cancer management, monoclonal antibodies, and the management of post-partum depression.
The Life Science, Health & Wellness TOE will feature disruptive technology advances in the global life sciences industry. The technologies and innovations profiled will encompass developments across genetic engineering, drug discovery and development, biomarkers, tissue engineering, synthetic biology, microbiome, disease management, as well as health and wellness among several other platforms.
The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.
Table of Contents
1. Advances in Stem Cells, Cellular Therapies, Diabetes Therapy, Gene Therapies, Antiaging Research, Biomarkers, and Vaccines
- Celularity
- Rubius Therapeutics
- Magenta Therapeutics
- Semma Therapeutics
- Orig3n
- University of California San Francisco (UCSF)
- UCSF
- MeiraGTx
- Boston University School of Medicine
- Gero
- Epitopoietic Research Corporation
- Provention Bio
- Sage Therapeutics
- Basilea Pharmaceutica
- Exelixis
- NYU
- University of Washington
- Roslin Institute Features of chicken eggs as bioreactors
- ESCO Aster
- Agenus
- Indian Institute of Technology, Mandi
- Liverpool School of Tropical Medicine
- University of Chicago
- UroGen
- Unity Biotechnology
- Bruin Biometrics
- Teva Pharmaceutical Industries
- Key Contacts
- Your F&S Thought Leader
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Agenus
- Basilea Pharmaceutica
- Boston University School of Medicine
- Bruin Biometrics
- Celularity
- ESCO Aster
- Epitopoietic Research Corporation
- Exelixis
- Gero
- Indian Institute of Technology, Mandi
- Liverpool School of Tropical Medicine
- Magenta Therapeutics
- MeiraGTx
- NYU
- Orig3n
- Provention Bio
- Roslin Institute Features of chicken eggs as bioreactors
- Rubius Therapeutics
- Sage Therapeutics
- Semma Therapeutics
- Teva Pharmaceutical Industries
- UCSF
- Unity Biotechnology
- University of California San Francisco (UCSF)
- University of Chicago
- University of Washington
- UroGen
